NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (OTC: PRWP), a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that Company executives are scheduled to present a corporate update at Rodman and Renshaw’s Annual Global Investment Conference on Monday, September 13, 2010 at 4:30 pm EDT at The New York Palace Hotel in New York City. The presentation is scheduled to be webcast live and can be accessed at: http://www.wsw.com/webcast/rrshq18/prw/.
